R207910
R207910 is an experimental anti-tuberculosis drug.[1]
References
References
- ↑ de Jonge MR, Koymans LH, Guillemont JE, Koul A, Andries K (2007). “A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910”. Proteins. 67 (4): 971–80. doi:10.1002/prot.21376. PMID 17387738.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH